Login or sign up
For business

ALX Oncology

4.2ยท 11 reviews
Average ratingGreat
4.2/ 5

Based on 11 reviews

536%
445%
318%
20%
10%
Ask AI

Ask Trustburn about ALX Oncology

Based on 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Matt Renner
Reviews 1

I had a wonderful experience with ALX Oncology. Their website is user-friendly and provides all the necessary information about their services. The staff was professional and attentive, making me feel comfortable throughout my treatment. The facilities were clean and well-maintained. Overall, I highly recommend ALX Oncology for their exceptional service.

Eric Wang
Reviews 1

The services provided by this company are top-notch. I was impressed with the level of professionalism and expertise demonstrated by their team. The website is easy to navigate and provides all the information I needed. I would definitely recommend their services to others.

Estee Woods
Reviews 1

ALX Oncology exceeded my expectations. From the moment I visited their website, I knew I was in good hands. The information provided was comprehensive and easy to understand. The staff was attentive and caring throughout my treatment. I am grateful to have found such a reliable company.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company.

The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University. This discovery involves soluble versions of signal regulatory protein-ฮฑ (SIRPฮฑ) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPฮฑ.1.